United States - English - NLM (National Library of Medicine)

remedyrepack inc. - carbamazepine (unii: 33cm23913m) (carbamazepine - unii:33cm23913m) - carbamazepine is indicated for use as an anticonvulsant drug. evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: - partial seizures with complex symptomatology (psychomotor, temporal lobe). patients with these seizures appear to show greater improvement than those with other types. - generalized tonic-clonic seizures (grand mal). - mixed seizure patterns which include the above, or other partial or generalized seizures. absence seizures (petit mal) do not appear to be controlled by carbamazepine (see precautions, general). carbamazepine is indicated in the treatment of the pain associated with true trigeminal neuralgia. beneficial results have also been reported in glossopharyngeal neuralgia. this drug is not a simple analgesic and should not be used for the relief of trivial aches or pains. carbamazepine should not be used in patients with a history of previous bone marrow depression, hypersensitivity to the drug, or known sensitivity to any of the tricyclic compounds, such as amitriptyline, desipramine, imipramine, protriptyline, nortriptyline, etc. likewise, on theoretical grounds its use with monoamine oxidase (mao) inhibitors is not recommended. before administration of carbamazepine, mao inhibitors should be discontinued for a minimum of 14 days, or longer if the clinical situation permits. coadministration of carbamazepine and nefazodone may result in insufficient plasma concentrations of nefazodone and its active metabolite to achieve a therapeutic effect. coadministration of carbamazepine with nefazodone is contraindicated. no evidence of abuse potential has been associated with carbamazepine, nor is there evidence of psychological or physical dependence in humans.

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novo nordisk a/s - liraglutide - solution for s/c injection - 6mg/ml

United States - English - NLM (National Library of Medicine)

viela bio, inc. - inebilizumab (unii: 74t7185bmm) (inebilizumab - unii:74t7185bmm) - uplizna is indicated for the treatment of neuromyelitis optica spectrum disorder (nmosd) in adult patients who are anti-aquaporin-4 (aqp4) antibody positive. uplizna is contraindicated in patients with: - a history of a life-threatening infusion reaction to uplizna [see warnings and precautions ( 5.1 )] - active hepatitis b infection [see warnings and precautions ( 5.2 )] - active or untreated latent tuberculosis [see warnings and precautions ( 5.2 )] risk summary uplizna is a humanized igg1 monoclonal antibody and immunoglobulins are known to cross the placental barrier. there are no adequate data on the developmental risk associated with the use of uplizna in pregnant women. however, transient peripheral b-cell depletion and lymphocytopenia have been reported in infants born to mothers exposed to other b-cell depleting antibodies during pregnancy. b-cell levels in infants following maternal exposure to uplizna have not been studied in clinical trials. the potential duration of b-cell depletion in such infan

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - alprazolam (unii: yu55mq3izy) (alprazolam - unii:yu55mq3izy) - alprazolam extended-release tablets are indicated for the treatment of panic disorder with or without agoraphobia, in adults. alprazolam extended-release tablets are contraindicated in patients: - with known hypersensitivity to alprazolam or other benzodiazepines. angioedema has been reported [see adverse reactions (6.2)] . - taking strong cytochrome p450 3a (cyp3a) inhibitors (e.g., ketoconazole, itraconazole), except ritonavir [see dosage and administration (2.5), warnings and precautions (5.5), drug interactions (7.1)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to alprazolam extended-release tablets during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for other psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/othermedications/. risk summary neonates born to mothers using ben

Canada - English - Health Canada

naka sales ltd. - ascorbic acid (ascorbic acid, sodium ascorbate); zinc (zinc gluconate, zinc hvp chelate) - lozenge - 150mg; 10mg - ascorbic acid (ascorbic acid, sodium ascorbate) 150mg; zinc (zinc gluconate, zinc hvp chelate) 10mg - vitamins & minerals

United States - English - NLM (National Library of Medicine)

rodan & fields - avobenzone 2% homosalate 7% octisalate 4% octocrylene 1.7% - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures (see ), decreases the risk of skin cancer and early skin aging caused by the sun directions

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

dansac ltd -

United States - English - NLM (National Library of Medicine)

donavan - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - aids in the prevention of dental cavities. expiration date: expiration date and batch no. on crimp of tube.

United States - English - NLM (National Library of Medicine)

asclemed usa, inc. - isopropyl alcohol (unii: nd2m416302) (isopropyl alcohol - unii:nd2m416302) - purpose: antiseptic uses for first aid to decrease germs in - minor cuts - scrapes - burns for preparation of the skin prior to injection

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

instituto grifols, spain - albumin human - solution - 20 %